Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Mills

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Human Immunology|February 2, 2020
Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 ~ DQB1) typing in a large cohort of adults with suspected celiac diseaseRok Seon Choung, John R Mills, Melissa R Snyder, et al.
Muscle & Nerve|April 25, 2025
Twenty Years Later, "AL Amyloidoma" Not "Non-Mutated ApoA1": Enhanced Diagnosis Through Mass Spectrometry AdvancementTony Zhang, David Dingli, David L Murry, et al.
JAMA Neurology|October 29, 2019
Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric PatientsAmy Kunchok, John J Chen, Andrew McKeon, et al.
Journal of the Neurological Sciences|July 19, 2020
False-positive anti-neuronal nuclear antibody type 1 in a patient with RFC1 repeat expansion: Preventing "phenotype creep" in autoimmune neurologyAdrian Budhram, John R Mills, Kamal Shouman, et al.
Clinical Biochemistry|March 10, 2021
Clearing drug interferences in myeloma treatment using mass spectrometryMindy C Kohlhagen, John R Mills, Maria A V Willrich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2019
Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgGJiraporn Jitprapaikulsan, C J Klein, Sean J Pittock, et al.
Cell Reports|May 31, 2016
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4AJennifer Chu, Gabriela Galicia-Vázquez, Regina Cencic, et al.
Blood|June 13, 2018
A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interferenceJohn R Mills, Mindy C Kohlhagen, Maria A V Willrich, et al.
Mayo Clinic Proceedings|October 5, 2021
HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma DonorsJustin E Juskewitch, Jonathon W Senefeld, Patrick W Johnson, et al.
Endocrine Pathology|June 25, 2017
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127)Sounak Gupta, Jun Zhang, Dragana Milosevic, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Human Immunology|February 2, 2020
Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 ~ DQB1) typing in a large cohort of adults with suspected celiac diseaseRok Seon Choung, John R Mills, Melissa R Snyder, et al.
Muscle & Nerve|April 25, 2025
Twenty Years Later, "AL Amyloidoma" Not "Non-Mutated ApoA1": Enhanced Diagnosis Through Mass Spectrometry AdvancementTony Zhang, David Dingli, David L Murry, et al.
JAMA Neurology|October 29, 2019
Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric PatientsAmy Kunchok, John J Chen, Andrew McKeon, et al.
Journal of the Neurological Sciences|July 19, 2020
False-positive anti-neuronal nuclear antibody type 1 in a patient with RFC1 repeat expansion: Preventing "phenotype creep" in autoimmune neurologyAdrian Budhram, John R Mills, Kamal Shouman, et al.
Clinical Biochemistry|March 10, 2021
Clearing drug interferences in myeloma treatment using mass spectrometryMindy C Kohlhagen, John R Mills, Maria A V Willrich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2019
Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgGJiraporn Jitprapaikulsan, C J Klein, Sean J Pittock, et al.
Cell Reports|May 31, 2016
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4AJennifer Chu, Gabriela Galicia-Vázquez, Regina Cencic, et al.
Blood|June 13, 2018
A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interferenceJohn R Mills, Mindy C Kohlhagen, Maria A V Willrich, et al.
Mayo Clinic Proceedings|October 5, 2021
HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma DonorsJustin E Juskewitch, Jonathon W Senefeld, Patrick W Johnson, et al.
Endocrine Pathology|June 25, 2017
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127)Sounak Gupta, Jun Zhang, Dragana Milosevic, et al.
Pageof 12